CX3CL1 and early-onset autosomal dominant Alzheimer disease: Considering these reports, and the apparent correlation between brain and blood levels, it has been proposed that plasma concentrations of CX3CL1 could be used as an additional marker to diagnose Alzheimer’s disease.